KLRK1 and neoplasm: While no advantage in overall survival was observed during the limited follow-up period, the accelerated tumor shrinkage in mice treated with the combined therapy presents an opportunity for further study to investigate and demonstrate more notable effects of combining radiotherapy with NKG2D CAR-T cells for ESCC.